CXM:NYSESprinklr, Inc. Analysis
Data as of 2026-08-08 - not real-time
$6.86
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $6.86, Sprinklr, Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have gained 39.7%. Momentum indicators put RSI at 72.1 (overbought) with MACD reading bullish. Price has been bracketed by support at $5.44 and resistance at $6.90.
Multiples put this in overvalued territory: 57.2 times earnings against the sector's 36.1. Analyst price targets sit 14.8% above the current price. Revenue is growing at 6.8% on a 3.3% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 39.7%, a beta of 0.33 and a maximum drawdown of 44.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Multiples put this in overvalued territory: 57.2 times earnings against the sector's 36.1. Analyst price targets sit 14.8% above the current price. Revenue is growing at 6.8% on a 3.3% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 39.7%, a beta of 0.33 and a maximum drawdown of 44.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
Sprinklr NYSE:CXM appointed Thomas Addis as Chief Revenue Officer, adding experienced revenue leadership to its...Seeking Alpha23dSprinklr: Slashed Growth Outlook Leaves Shares Deeply DiscountedSprinklr is rated a buy with a $6.As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the sales and marketing...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- RSI at 72.1 signals overbought conditions
- Trading above the 200-day average of 6.24
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- RSI at 72.1 signals overbought conditions
- P/E of 57.2 versus sector average of 36.1
- Trading above the 200-day average of 6.24
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 57.2 versus sector average of 36.1
- Analyst targets imply +14.8% versus the current price
- Price-to-book of 3.29
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin3.29%
P/E Ratio57.2
ROE5.08%
ROA2.91%
Debt/Equity8.97
P/B Ratio3.3
Op. Cash Flow$145.8M
Free Cash Flow$130.2M
Industry P/E36.1
Technical Analysis
TrendNeutral
RSI72.1
Support$5.44
Resistance$6.90
MA 20$6.10
MA 50$5.64
MA 200$6.24
MACDBullish
VolumeStable
Fear & Greed Index94.82
Valuation
Fair Value$11.20
Target Price$7.88
Upside/Downside14.80%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.33
Volatility39.69%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.